Alta Wealth Advisors’s CalciMedica CALC Stock Holding History

Alta Wealth Advisors’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-769	Closed	-$58K	–	144
2021 Q2	$58K	Hold	769	–	–	0.04%	143
2021 Q1	$60K	Buy	+769	New	+$230K	0.05%	131

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alta Wealth Advisors's CALC Position: Q3 2021 in Review

Alta Wealth Advisors sold out of CalciMedica (CALC) in Q3 2021, closing a stake of 769 shares — an estimated $58K sold.

Alta Wealth Advisors first reported a position in CALC in Q1 2021 and held it in 2 quarters. The position peaked at $60K in Q1 2021. 27 funds tracked by Wall St. Rank hold CALC as of Q3 2021.

Alta Wealth Advisors reported no remaining CalciMedica position as of Q3 2021 after selling out during the quarter.
Alta Wealth Advisors sold 769 CalciMedica shares in Q3 2021, an estimated $58K.
Alta Wealth Advisors first reported a position in CalciMedica in Q1 2021 and held it in 2 quarters.
Alta Wealth Advisors's CalciMedica position peaked at $60K in Q1 2021.
27 funds tracked by Wall St. Rank held CalciMedica as of Q3 2021.

Based on Alta Wealth Advisors's 13F filing for Q3 2021, filed 13 Oct 2021.